amphetamine has been researched along with Neurodegenerative Diseases in 6 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leino, S | 1 |
| Koski, SK | 1 |
| Hänninen, R | 1 |
| Tapanainen, T | 1 |
| Rannanpää, S | 1 |
| Salminen, O | 1 |
| Butler, B | 1 |
| Saha, K | 1 |
| Rana, T | 1 |
| Becker, JP | 1 |
| Sambo, D | 1 |
| Davari, P | 1 |
| Goodwin, JS | 1 |
| Khoshbouei, H | 1 |
| Vomund, S | 1 |
| de Souza Silva, MA | 1 |
| Huston, JP | 1 |
| Korth, C | 1 |
| Decressac, M | 2 |
| Ulusoy, A | 1 |
| Mattsson, B | 2 |
| Georgievska, B | 1 |
| Romero-Ramos, M | 1 |
| Kirik, D | 1 |
| Björklund, A | 2 |
| Lundblad, M | 1 |
| Weikop, P | 1 |
| Bowyer, JF | 1 |
| Harris, AJ | 1 |
| Delongchamp, RR | 1 |
| Jakab, RL | 1 |
| Miller, DB | 1 |
| Little, AR | 1 |
| O'Callaghan, JP | 1 |
6 other studies available for amphetamine and Neurodegenerative Diseases
| Article | Year |
|---|---|
Attenuated dopaminergic neurodegeneration and motor dysfunction in hemiparkinsonian mice lacking the α5 nicotinic acetylcholine receptor subunit.
Topics: Amphetamine; Animals; Antiparkinson Agents; Brain; Central Nervous System Stimulants; Dopamine; Dopa | 2018 |
Dopamine Transporter Activity Is Modulated by α-Synuclein.
Topics: alpha-Synuclein; Amphetamine; Animals; Biotinylation; Brain; Cell Line; Cell Membrane; CHO Cells; Cr | 2015 |
Behavioral Resilience and Sensitivity to Locally Restricted Cortical Migration Deficits Induced by In Utero Knockdown of Disabled-1 in the Adult Rat.
Topics: Adaptor Proteins, Signal Transducing; Amphetamine; Animals; Cell Line, Tumor; Cell Movement; Central | 2017 |
GDNF fails to exert neuroprotection in a rat α-synuclein model of Parkinson's disease.
Topics: Amphetamine; Animals; Animals, Genetically Modified; Cell Count; Corpus Striatum; Disease Models, An | 2011 |
Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.
Topics: alpha-Synuclein; Amphetamine; Analysis of Variance; Animals; Antiparkinson Agents; Behavioral Sympto | 2012 |
Selective changes in gene expression in cortical regions sensitive to amphetamine during the neurodegenerative process.
Topics: Amphetamine; Animals; Cerebral Cortex; Dopamine; Gene Expression Regulation; Male; Neurodegenerative | 2004 |